{
    "info": {
        "nct_id": "NCT06467357",
        "official_title": "DESTINY-Biliary Tract Cancer-01: A Phase 3 Study of Trastuzumab Deruxtecan (T-DXd) and Rilvegostomig Versus Standard-of-Care Gemcitabine, Cisplatin, and Durvalumab for First Line Locally Advanced or Metastatic HER2-expressing Biliary Tract Cancer",
        "inclusion_criteria": "* Participants must be ≥ 18 years of age at the time of screening. Other age restrictions may apply as per local regulations;\n* Male and female;\n* Unresectable, previously untreated, locally advanced or metastatic BTC. Prior treatment in the perioperative and/or adjuvant setting is permissible provided there is > 6 months (180 days) between the end of adjuvant treatment and the diagnosis of locally advanced or metastatic disease.\n* histologically confirmed HER2-expressing (IHC 3+ or IHC 2+) BTC;\n* Provision of FFPE tumor sample that is no older than 3 years;\n* At least one target lesion assessed by the Investigator based on RECIST v1.1 (randomized portion only);\n* WHO/ECOG performance status of 0 or 1;\n* Adequate organ and bone marrow function within 14 days before randomization;\n* Evidence of post-menopausal status or negative serum pregnancy test for females of childbearing potential;\n\nKey\nHealthy volunteers allowed\nMust have minimum age of 18 Years\nMust have maximum age of 99 Years",
        "exclusion_criteria": "* Prior exposure to other HER2 targeting therapies, ADCs, immune checkpoint inhibitors and therapeutic anticancer vaccines;\n* histologically confirmed ampullary carcinoma;\n* history of substance abuse or any other medical conditions such as clinically significant cardiac or psychological conditions;\n* spinal cord compression or clinically active central nervous system metastases, defined as untreated and symptomatic, or requiring therapy with corticosteroids or anticonvulsants to control associated symptoms;\n* medical history of myocardial infarction within 6 months before randomization/enrollment, symptomatic congestive heart failure (New York Heart Association Class II to IV), unstable angina pectoris, clinically important cardiac arrhythmias, or a recent (< 6 months) cardiovascular event including stroke;\n* Serious chronic gastrointestinal conditions associated with diarrhea (eg, active inflammatory bowel disease); active non-infectious skin disease (including any grade rash, urticaria, dermatitis, ulceration, or psoriasis) requiring systemic treatment;\n* active autoimmune, connective tissue or inflammatory disorders that has required systemic treatment in the past 2 years, or where there is documented, or a suspicion of pulmonary involvement at the time of screening;\n* Corrected QT interval (QTcF) prolongation to > 470 msec (females) or > 450 msec (males) based on average of the screening triplicate 12-lead ECG;\n* History of (non-infectious) ILD/pneumonitis, has current ILD/pneumonitis, or where suspected ILD/pneumonitis cannot be ruled out by imaging at screening;\n* Lung-specific intercurrent clinically significant illnesses including, but not limited to, any underlying pulmonary disorder;\n* Prior pneumonectomy (complete);\n* Uncontrolled infection requiring IV antibiotics, antivirals, or antifungals;\n* Active primary immunodeficiency, known uncontrolled active HIV infection or HCV;\n* Pregnant or breastfeeding female patients, or patients who are planning to become pregnant;\n* Participation in another clinical study with a study intervention or investigational medicinal device administered in the last 6 months prior to randomization, or concurrent enrollment in another clinical study, unless it is an observational (non-interventional) clinical study or during the follow-up period of an interventional study (only randomized portion).",
        "miscellaneous_criteria": "Key"
    },
    "inclusion_lines": [
        {
            "line": "* Male and female;",
            "criterions": [
                {
                    "exact_snippets": "Male and female;",
                    "criterion": "sex",
                    "requirements": [
                        {
                            "requirement_type": "allowed_values",
                            "expected_value": [
                                "male",
                                "female"
                            ]
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Evidence of post-menopausal status or negative serum pregnancy test for females of childbearing potential;",
            "criterions": [
                {
                    "exact_snippets": "Evidence of post-menopausal status",
                    "criterion": "menopausal status",
                    "requirements": [
                        {
                            "requirement_type": "status",
                            "expected_value": "post-menopausal"
                        }
                    ]
                },
                {
                    "exact_snippets": "negative serum pregnancy test for females of childbearing potential",
                    "criterion": "serum pregnancy test",
                    "requirements": [
                        {
                            "requirement_type": "result",
                            "expected_value": "negative"
                        },
                        {
                            "requirement_type": "applicability",
                            "expected_value": "females of childbearing potential"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Participants must be ≥ 18 years of age at the time of screening. Other age restrictions may apply as per local regulations;",
            "criterions": [
                {
                    "exact_snippets": "Participants must be ≥ 18 years of age at the time of screening.",
                    "criterion": "age",
                    "requirements": [
                        {
                            "requirement_type": "age at screening",
                            "expected_value": {
                                "operator": ">=",
                                "value": 18,
                                "unit": "years"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "Other age restrictions may apply as per local regulations",
                    "criterion": "age",
                    "requirements": [
                        {
                            "requirement_type": "age restrictions per local regulations",
                            "expected_value": "as per local regulations"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* At least one target lesion assessed by the Investigator based on RECIST v1.1 (randomized portion only);",
            "criterions": [
                {
                    "exact_snippets": "At least one target lesion assessed by the Investigator based on RECIST v1.1",
                    "criterion": "target lesion",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">=",
                                "value": 1,
                                "unit": "lesion"
                            }
                        },
                        {
                            "requirement_type": "assessment_method",
                            "expected_value": "RECIST v1.1"
                        },
                        {
                            "requirement_type": "assessor",
                            "expected_value": "Investigator"
                        }
                    ]
                }
            ]
        },
        {
            "line": "Must have minimum age of 18 Years",
            "criterions": [
                {
                    "exact_snippets": "minimum age of 18 Years",
                    "criterion": "age",
                    "requirements": [
                        {
                            "requirement_type": "minimum",
                            "expected_value": {
                                "operator": ">=",
                                "value": 18,
                                "unit": "years"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "Healthy volunteers allowed",
            "criterions": [
                {
                    "exact_snippets": "Healthy volunteers allowed",
                    "criterion": "healthy volunteer status",
                    "requirements": [
                        {
                            "requirement_type": "eligibility",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* WHO/ECOG performance status of 0 or 1;",
            "criterions": [
                {
                    "exact_snippets": "WHO/ECOG performance status of 0 or 1",
                    "criterion": "WHO/ECOG performance status",
                    "requirements": [
                        {
                            "requirement_type": "value",
                            "expected_value": {
                                "comparisons": [
                                    {
                                        "operator": ">=",
                                        "value": 0,
                                        "unit": ""
                                    },
                                    {
                                        "operator": "<=",
                                        "value": 1,
                                        "unit": ""
                                    }
                                ]
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Unresectable, previously untreated, locally advanced or metastatic BTC. Prior treatment in the perioperative and/or adjuvant setting is permissible provided there is > 6 months (180 days) between the end of adjuvant treatment and the diagnosis of locally advanced or metastatic disease.",
            "criterions": [
                {
                    "exact_snippets": "Unresectable",
                    "criterion": "disease resectability",
                    "requirements": [
                        {
                            "requirement_type": "resectability",
                            "expected_value": "unresectable"
                        }
                    ]
                },
                {
                    "exact_snippets": "previously untreated",
                    "criterion": "prior treatment for advanced/metastatic BTC",
                    "requirements": [
                        {
                            "requirement_type": "treatment history",
                            "expected_value": false
                        }
                    ]
                },
                {
                    "exact_snippets": "locally advanced or metastatic BTC",
                    "criterion": "BTC disease stage",
                    "requirements": [
                        {
                            "requirement_type": "stage",
                            "expected_value": [
                                "locally advanced",
                                "metastatic"
                            ]
                        }
                    ]
                },
                {
                    "exact_snippets": "Prior treatment in the perioperative and/or adjuvant setting is permissible provided there is > 6 months (180 days) between the end of adjuvant treatment and the diagnosis of locally advanced or metastatic disease.",
                    "criterion": "interval between end of adjuvant treatment and diagnosis of advanced/metastatic disease",
                    "requirements": [
                        {
                            "requirement_type": "time interval",
                            "expected_value": {
                                "operator": ">",
                                "value": 6,
                                "unit": "months"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* histologically confirmed HER2-expressing (IHC 3+ or IHC 2+) BTC;",
            "criterions": [
                {
                    "exact_snippets": "histologically confirmed",
                    "criterion": "diagnosis confirmation method",
                    "requirements": [
                        {
                            "requirement_type": "method",
                            "expected_value": "histology"
                        }
                    ]
                },
                {
                    "exact_snippets": "HER2-expressing (IHC 3+ or IHC 2+)",
                    "criterion": "HER2 expression in tumor",
                    "requirements": [
                        {
                            "requirement_type": "IHC score",
                            "expected_value": [
                                "3+",
                                "2+"
                            ]
                        }
                    ]
                },
                {
                    "exact_snippets": "BTC",
                    "criterion": "biliary tract cancer (BTC)",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "Key",
            "criterions": [
                {
                    "exact_snippets": "Key",
                    "criterion": "key status",
                    "requirements": [
                        {
                            "requirement_type": "N/A",
                            "expected_value": "Key"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Provision of FFPE tumor sample that is no older than 3 years;",
            "criterions": [
                {
                    "exact_snippets": "Provision of FFPE tumor sample",
                    "criterion": "FFPE tumor sample",
                    "requirements": [
                        {
                            "requirement_type": "provision",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "no older than 3 years",
                    "criterion": "FFPE tumor sample age",
                    "requirements": [
                        {
                            "requirement_type": "age",
                            "expected_value": {
                                "operator": "<=",
                                "value": 3,
                                "unit": "years"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Adequate organ and bone marrow function within 14 days before randomization;",
            "criterions": [
                {
                    "exact_snippets": "Adequate organ ... function within 14 days before randomization",
                    "criterion": "organ function",
                    "requirements": [
                        {
                            "requirement_type": "adequacy",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "timeframe",
                            "expected_value": {
                                "operator": "<=",
                                "value": 14,
                                "unit": "days before randomization"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "Adequate ... bone marrow function within 14 days before randomization",
                    "criterion": "bone marrow function",
                    "requirements": [
                        {
                            "requirement_type": "adequacy",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "timeframe",
                            "expected_value": {
                                "operator": "<=",
                                "value": 14,
                                "unit": "days before randomization"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "Must have maximum age of 99 Years",
            "criterions": [
                {
                    "exact_snippets": "maximum age of 99 Years",
                    "criterion": "age",
                    "requirements": [
                        {
                            "requirement_type": "maximum",
                            "expected_value": {
                                "operator": "<=",
                                "value": 99,
                                "unit": "Years"
                            }
                        }
                    ]
                }
            ]
        }
    ],
    "exclusion_lines": [
        {
            "line": "* History of (non-infectious) ILD/pneumonitis, has current ILD/pneumonitis, or where suspected ILD/pneumonitis cannot be ruled out by imaging at screening;",
            "criterions": [
                {
                    "exact_snippets": "History of (non-infectious) ILD/pneumonitis",
                    "criterion": "interstitial lung disease (ILD)/pneumonitis",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "infectious status",
                            "expected_value": "non-infectious"
                        }
                    ]
                },
                {
                    "exact_snippets": "has current ILD/pneumonitis",
                    "criterion": "interstitial lung disease (ILD)/pneumonitis",
                    "requirements": [
                        {
                            "requirement_type": "current presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "suspected ILD/pneumonitis cannot be ruled out by imaging at screening",
                    "criterion": "interstitial lung disease (ILD)/pneumonitis",
                    "requirements": [
                        {
                            "requirement_type": "suspected by imaging at screening",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Participation in another clinical study with a study intervention or investigational medicinal device administered in the last 6 months prior to randomization, or concurrent enrollment in another clinical study, unless it is an observational (non-interventional) clinical study or during the follow-up period of an interventional study (only randomized portion).",
            "criterions": [
                {
                    "exact_snippets": "Participation in another clinical study with a study intervention or investigational medicinal device administered in the last 6 months prior to randomization",
                    "criterion": "participation in another clinical study with a study intervention or investigational medicinal device",
                    "requirements": [
                        {
                            "requirement_type": "recency",
                            "expected_value": {
                                "operator": "<=",
                                "value": 6,
                                "unit": "months"
                            }
                        },
                        {
                            "requirement_type": "timing",
                            "expected_value": "prior to randomization"
                        }
                    ]
                },
                {
                    "exact_snippets": "concurrent enrollment in another clinical study, unless it is an observational (non-interventional) clinical study or during the follow-up period of an interventional study (only randomized portion)",
                    "criterion": "concurrent enrollment in another clinical study",
                    "requirements": [
                        {
                            "requirement_type": "concurrent_enrollment",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "study_type_exclusion",
                            "expected_value": [
                                "observational (non-interventional) clinical study",
                                "follow-up period of an interventional study (only randomized portion)"
                            ]
                        }
                    ]
                }
            ]
        },
        {
            "line": "* histologically confirmed ampullary carcinoma;",
            "criterions": [
                {
                    "exact_snippets": "histologically confirmed ampullary carcinoma",
                    "criterion": "ampullary carcinoma",
                    "requirements": [
                        {
                            "requirement_type": "diagnosis",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "confirmation method",
                            "expected_value": "histological"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* history of substance abuse or any other medical conditions such as clinically significant cardiac or psychological conditions;",
            "criterions": [
                {
                    "exact_snippets": "history of substance abuse",
                    "criterion": "substance abuse",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "clinically significant cardiac ... conditions",
                    "criterion": "cardiac conditions",
                    "requirements": [
                        {
                            "requirement_type": "clinical significance",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "clinically significant ... psychological conditions",
                    "criterion": "psychological conditions",
                    "requirements": [
                        {
                            "requirement_type": "clinical significance",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Prior exposure to other HER2 targeting therapies, ADCs, immune checkpoint inhibitors and therapeutic anticancer vaccines;",
            "criterions": [
                {
                    "exact_snippets": "Prior exposure to other HER2 targeting therapies",
                    "criterion": "prior exposure to HER2 targeting therapies",
                    "requirements": [
                        {
                            "requirement_type": "history of exposure",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "Prior exposure to ... ADCs",
                    "criterion": "prior exposure to ADCs (antibody-drug conjugates)",
                    "requirements": [
                        {
                            "requirement_type": "history of exposure",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "Prior exposure to ... immune checkpoint inhibitors",
                    "criterion": "prior exposure to immune checkpoint inhibitors",
                    "requirements": [
                        {
                            "requirement_type": "history of exposure",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "Prior exposure to ... therapeutic anticancer vaccines",
                    "criterion": "prior exposure to therapeutic anticancer vaccines",
                    "requirements": [
                        {
                            "requirement_type": "history of exposure",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* spinal cord compression or clinically active central nervous system metastases, defined as untreated and symptomatic, or requiring therapy with corticosteroids or anticonvulsants to control associated symptoms;",
            "criterions": [
                {
                    "exact_snippets": "spinal cord compression",
                    "criterion": "spinal cord compression",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "clinically active central nervous system metastases, defined as untreated and symptomatic, or requiring therapy with corticosteroids or anticonvulsants to control associated symptoms",
                    "criterion": "central nervous system metastases",
                    "requirements": [
                        {
                            "requirement_type": "activity status",
                            "expected_value": "clinically active"
                        },
                        {
                            "requirement_type": "treatment status",
                            "expected_value": "untreated"
                        },
                        {
                            "requirement_type": "symptom status",
                            "expected_value": "symptomatic"
                        },
                        {
                            "requirement_type": "therapy requirement",
                            "expected_value": [
                                "corticosteroids",
                                "anticonvulsants"
                            ]
                        }
                    ]
                }
            ]
        },
        {
            "line": "* medical history of myocardial infarction within 6 months before randomization/enrollment, symptomatic congestive heart failure (New York Heart Association Class II to IV), unstable angina pectoris, clinically important cardiac arrhythmias, or a recent (< 6 months) cardiovascular event including stroke;",
            "criterions": [
                {
                    "exact_snippets": "medical history of myocardial infarction within 6 months before randomization/enrollment",
                    "criterion": "myocardial infarction",
                    "requirements": [
                        {
                            "requirement_type": "history_within_timeframe",
                            "expected_value": {
                                "operator": "<=",
                                "value": 6,
                                "unit": "months"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "symptomatic congestive heart failure (New York Heart Association Class II to IV)",
                    "criterion": "congestive heart failure",
                    "requirements": [
                        {
                            "requirement_type": "symptomatic",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "NYHA_class",
                            "expected_value": {
                                "operator": ">=",
                                "value": 2,
                                "unit": "NYHA class"
                            }
                        },
                        {
                            "requirement_type": "NYHA_class",
                            "expected_value": {
                                "operator": "<=",
                                "value": 4,
                                "unit": "NYHA class"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "unstable angina pectoris",
                    "criterion": "unstable angina pectoris",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "clinically important cardiac arrhythmias",
                    "criterion": "cardiac arrhythmias",
                    "requirements": [
                        {
                            "requirement_type": "clinical_importance",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "a recent (< 6 months) cardiovascular event including stroke",
                    "criterion": "cardiovascular event (including stroke)",
                    "requirements": [
                        {
                            "requirement_type": "history_within_timeframe",
                            "expected_value": {
                                "operator": "<",
                                "value": 6,
                                "unit": "months"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Active primary immunodeficiency, known uncontrolled active HIV infection or HCV;",
            "criterions": [
                {
                    "exact_snippets": "Active primary immunodeficiency",
                    "criterion": "primary immunodeficiency",
                    "requirements": [
                        {
                            "requirement_type": "activity",
                            "expected_value": "active"
                        }
                    ]
                },
                {
                    "exact_snippets": "known uncontrolled active HIV infection",
                    "criterion": "HIV infection",
                    "requirements": [
                        {
                            "requirement_type": "control status",
                            "expected_value": "uncontrolled"
                        },
                        {
                            "requirement_type": "activity",
                            "expected_value": "active"
                        },
                        {
                            "requirement_type": "awareness",
                            "expected_value": "known"
                        }
                    ]
                },
                {
                    "exact_snippets": "HCV",
                    "criterion": "HCV infection",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Pregnant or breastfeeding female patients, or patients who are planning to become pregnant;",
            "criterions": [
                {
                    "exact_snippets": "Pregnant ... female patients",
                    "criterion": "pregnancy status",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "breastfeeding female patients",
                    "criterion": "breastfeeding status",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "patients who are planning to become pregnant",
                    "criterion": "pregnancy intention",
                    "requirements": [
                        {
                            "requirement_type": "intention to become pregnant",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* active autoimmune, connective tissue or inflammatory disorders that has required systemic treatment in the past 2 years, or where there is documented, or a suspicion of pulmonary involvement at the time of screening;",
            "criterions": [
                {
                    "exact_snippets": "active autoimmune, connective tissue or inflammatory disorders that has required systemic treatment in the past 2 years",
                    "criterion": "autoimmune, connective tissue or inflammatory disorders",
                    "requirements": [
                        {
                            "requirement_type": "activity",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "systemic treatment requirement (past 2 years)",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "pulmonary involvement at the time of screening",
                    "criterion": "pulmonary involvement",
                    "requirements": [
                        {
                            "requirement_type": "presence at screening",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Serious chronic gastrointestinal conditions associated with diarrhea (eg, active inflammatory bowel disease); active non-infectious skin disease (including any grade rash, urticaria, dermatitis, ulceration, or psoriasis) requiring systemic treatment;",
            "criterions": [
                {
                    "exact_snippets": "Serious chronic gastrointestinal conditions associated with diarrhea (eg, active inflammatory bowel disease)",
                    "criterion": "chronic gastrointestinal conditions associated with diarrhea",
                    "requirements": [
                        {
                            "requirement_type": "severity",
                            "expected_value": "serious"
                        },
                        {
                            "requirement_type": "chronicity",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "active inflammatory bowel disease",
                    "criterion": "inflammatory bowel disease",
                    "requirements": [
                        {
                            "requirement_type": "activity",
                            "expected_value": "active"
                        }
                    ]
                },
                {
                    "exact_snippets": "active non-infectious skin disease (including any grade rash, urticaria, dermatitis, ulceration, or psoriasis) requiring systemic treatment",
                    "criterion": "non-infectious skin disease",
                    "requirements": [
                        {
                            "requirement_type": "activity",
                            "expected_value": "active"
                        },
                        {
                            "requirement_type": "treatment requirement",
                            "expected_value": "systemic treatment"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Prior pneumonectomy (complete);",
            "criterions": [
                {
                    "exact_snippets": "Prior pneumonectomy (complete)",
                    "criterion": "prior pneumonectomy",
                    "requirements": [
                        {
                            "requirement_type": "completeness",
                            "expected_value": "complete"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Lung-specific intercurrent clinically significant illnesses including, but not limited to, any underlying pulmonary disorder;",
            "criterions": [
                {
                    "exact_snippets": "Lung-specific intercurrent clinically significant illnesses",
                    "criterion": "lung-specific intercurrent clinically significant illnesses",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": false
                        }
                    ]
                },
                {
                    "exact_snippets": "any underlying pulmonary disorder",
                    "criterion": "underlying pulmonary disorder",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": false
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Corrected QT interval (QTcF) prolongation to > 470 msec (females) or > 450 msec (males) based on average of the screening triplicate 12-lead ECG;",
            "criterions": [
                {
                    "exact_snippets": "Corrected QT interval (QTcF) prolongation to > 470 msec (females) or > 450 msec (males) based on average of the screening triplicate 12-lead ECG",
                    "criterion": "corrected QT interval (QTcF)",
                    "requirements": [
                        {
                            "requirement_type": "duration (females)",
                            "expected_value": {
                                "operator": ">",
                                "value": 470,
                                "unit": "msec"
                            }
                        },
                        {
                            "requirement_type": "duration (males)",
                            "expected_value": {
                                "operator": ">",
                                "value": 450,
                                "unit": "msec"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Uncontrolled infection requiring IV antibiotics, antivirals, or antifungals;",
            "criterions": [
                {
                    "exact_snippets": "Uncontrolled infection",
                    "criterion": "infection",
                    "requirements": [
                        {
                            "requirement_type": "control status",
                            "expected_value": "uncontrolled"
                        }
                    ]
                },
                {
                    "exact_snippets": "requiring IV antibiotics, antivirals, or antifungals",
                    "criterion": "infection treatment",
                    "requirements": [
                        {
                            "requirement_type": "treatment requirement",
                            "expected_value": [
                                "IV antibiotics",
                                "IV antivirals",
                                "IV antifungals"
                            ]
                        }
                    ]
                }
            ]
        }
    ],
    "miscellaneous_lines": [
        {
            "line": "Key",
            "criterions": [
                {
                    "exact_snippets": "Key",
                    "criterion": "key status",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        }
    ],
    "failed_inclusion": [],
    "failed_exclusion": [],
    "failed_miscellaneous": []
}